Healthcare & Life Sciences Industry Updates

Google News – EMA (biotech/pharma) External News

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

news.google.com · 08 Jul 2026

Google News – EMA (biotech/pharma) External News

WuXi Biologics Suzhou Center Passes EMA GMP Inspection - Contract Pharma

news.google.com · 08 Jul 2026

Google News – EMA (biotech/pharma) External News

MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg - Business Wire

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

Can a chaotic FDA still deliver on faster drug development? - Pharma Voice

news.google.com · 08 Jul 2026

Google News – Medical Devices External News

Microbial contamination of medicines, medical devices, cosmetics, child and personal care products: a comprehensive review of secondary contamination risks in home-use settings - Frontiers

news.google.com · 08 Jul 2026

Google News – Biopharma External News

Biopharma industry confidence at highest in years despite geopolitical headwinds - Clinical Trials Arena

news.google.com · 08 Jul 2026

Google News – Biopharma External News

Quantum BioPharma Provides Corporate Update - The Globe and Mail

news.google.com · 08 Jul 2026

Industry News External News

Broker’s Call: Mankind Pharma (Add) - BusinessLine

news.google.com · 08 Jul 2026

Industry News External News

Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger - BusinessLine

news.google.com · 08 Jul 2026

Google News – Biotech Funding External News

Fore Biotherapeutics secures $67M in one of year's largest biotech funding rounds - The Business Journals

news.google.com · 08 Jul 2026

Google News – Oncology External News

Werewolf Therapeutics outlines its immuno-oncology strategy as Nasdaq-listed biotech - AD HOC NEWS

news.google.com · 08 Jul 2026

Google News – Oncology External News

MEI Pharma Inc update amid limited public data - AD HOC NEWS

news.google.com · 08 Jul 2026

Google News – Oncology External News

Jazz orchestrates a $4bn cancer alliance with AbCellera - pharmaphorum

news.google.com · 08 Jul 2026

Google News – Oncology External News

Boehringer expands cancer vaccine push with Prime Vector licensing deal - The Pharma Letter

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment - PMLiVE

news.google.com · 08 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

WuXi Biologics Suzhou Center Passes EMA GMP Inspection - Contract Pharma

MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg - Business Wire

Can a chaotic FDA still deliver on faster drug development? - Pharma Voice

Microbial contamination of medicines, medical devices, cosmetics, child and personal care products: a comprehensive review of secondary contamination risks in home-use settings - Frontiers

Biopharma industry confidence at highest in years despite geopolitical headwinds - Clinical Trials Arena

Quantum BioPharma Provides Corporate Update - The Globe and Mail

Broker’s Call: Mankind Pharma (Add) - BusinessLine

Torrent Pharma, JB Chemicals hit 52-week highs after NCLT approves merger - BusinessLine

Fore Biotherapeutics secures $67M in one of year's largest biotech funding rounds - The Business Journals

Werewolf Therapeutics outlines its immuno-oncology strategy as Nasdaq-listed biotech - AD HOC NEWS

MEI Pharma Inc update amid limited public data - AD HOC NEWS

Jazz orchestrates a $4bn cancer alliance with AbCellera - pharmaphorum

Boehringer expands cancer vaccine push with Prime Vector licensing deal - The Pharma Letter

J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment - PMLiVE